Benzonatate Capsule
Product Images NDC 87519-111

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 87519-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anvi Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzonatate-struct (Benzonatate Struct)

Chemical structure diagram of Benzonatate showing its molecular formula C30H53NO11 with annotated structural groups including alkyl chains, aromatic ring, and ether linkages.*

FDA Label Image

150mg-90 Count (Benzonatate 150mg 90 Count)

Benzonatate Capsules, USP 150 mg label for oral capsules in a 90-count package. The label includes dosage strength, NDC 87519-111-90, manufacturer Anvi Pharmaceuticals Inc, and usage instructions indicating these are prescription-only capsules in a child-resistant container. Storage and patient information details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.